Journal of clinical research in pediatric endocrinology, vol.8, no.3, pp.313-20, 2016 (SCI-Expanded)
Article / Article
Journal of clinical research in pediatric endocrinology
Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
Type 1 diabetes mellitus, subclinical atherosclerosis, soluble endoglin, adolescents, FLOW-MEDIATED DILATION, TGF-BETA RECEPTOR, NITRIC-OXIDE, ASYMMETRIC DIMETHYLARGININE, ENDOTHELIAL DYSFUNCTION, CHILDREN, ATHEROSCLEROSIS, EXPRESSION, MELLITUS, CELLS
Gazi University Affiliated:
Objective: Soluble endoglin (S-endoglin) has been implicated as a potential marker of endothelial dysfunction (ED) and was reported to be elevated in diabetic adults, correlating with the severity of diabetic vasculopathy. However, circulating S-endoglin and its association with other markers of ED have not been formerly analyzed in the first decade of diabetes onset in adolescents with type 1 diabetes mellitus (T1DM).